Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TAL1 | hg38_v1_chr1_-_47231715_47231786 | 0.52 | 2.5e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr22_+_22697789 Show fit | 13.87 |
ENST00000390306.2
|
immunoglobulin lambda variable 2-23 |
|
chr14_-_106038355 Show fit | 13.77 |
ENST00000390597.3
|
immunoglobulin heavy variable 2-5 |
|
chr14_-_106349792 Show fit | 13.64 |
ENST00000438142.3
|
immunoglobulin heavy variable 4-31 |
|
chr14_-_106360320 Show fit | 12.01 |
ENST00000390615.2
|
immunoglobulin heavy variable 3-33 |
|
chr14_-_106422175 Show fit | 11.54 |
ENST00000390619.2
|
immunoglobulin heavy variable 4-39 |
|
chr2_-_89143133 Show fit | 11.21 |
ENST00000492167.1
|
immunoglobulin kappa variable 3-20 |
|
chr14_-_105940235 Show fit | 11.04 |
ENST00000390593.2
|
immunoglobulin heavy variable 6-1 |
|
chr14_-_106324743 Show fit | 10.97 |
ENST00000390612.3
|
immunoglobulin heavy variable 4-28 |
|
chr14_-_106715166 Show fit | 10.75 |
ENST00000390633.2
|
immunoglobulin heavy variable 1-69 |
|
chr14_-_106639589 Show fit | 10.73 |
ENST00000390630.3
|
immunoglobulin heavy variable 4-61 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 533.1 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.7 | 153.6 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.3 | 92.4 | GO:0002250 | adaptive immune response(GO:0002250) |
0.8 | 66.9 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 66.1 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.3 | 39.5 | GO:0031295 | T cell costimulation(GO:0031295) |
0.4 | 34.8 | GO:0006968 | cellular defense response(GO:0006968) |
2.2 | 31.2 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.2 | 24.3 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.4 | 21.4 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 206.6 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 153.6 | GO:0005615 | extracellular space(GO:0005615) |
0.6 | 126.0 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 87.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 82.4 | GO:0005576 | extracellular region(GO:0005576) |
0.4 | 39.9 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.3 | 36.2 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.2 | 34.3 | GO:0035578 | azurophil granule lumen(GO:0035578) |
2.2 | 26.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
1.2 | 25.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 466.8 | GO:0003823 | antigen binding(GO:0003823) |
3.1 | 221.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.3 | 50.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 32.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.5 | 24.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
2.1 | 20.7 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.6 | 20.7 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
1.2 | 19.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
1.1 | 17.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 17.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 88.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.7 | 42.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.4 | 38.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.3 | 35.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.3 | 21.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.5 | 21.1 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.3 | 19.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.4 | 14.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 12.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 12.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 78.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.4 | 48.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.6 | 40.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 37.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
1.4 | 28.8 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
1.5 | 28.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.3 | 23.7 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.8 | 21.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.4 | 17.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 16.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |